New chairman of the board for Varian

Kathy Mahdoubi | | Health Imaging | Molecular Imaging

Varian Medical Systems out of Palo Alto, Calif., elected Andrew Eckert, 52, as head of the board of directors, the manufacturer of radiation oncology technology announced Feb. 20. 

The new chairman is replacing 74-year-old Richard M. Levy, who has been leading the board since 2002. Eckert has been a member of Varian’s board of directors since 2004 and is currently CEO of CRC Health Corporation. He is also former CEO of SumTotal Systems, ADAC Laboratories and Eclipsys Corporation.  

"Under Dick's guidance, the company established itself as the world's leading innovator and supplier of products for treating cancer with radiation oncology,” remarked Eckert in a release. “Furthermore, the company has capitalized on components technology developed under Dick's leadership to advance the science and benefits of X-ray imaging."

Varian’s technology centers on detector technology and systems used in radiotherapy, radiosurgery and brachytherapy. Eckert’s leadership of the board of directors took effect Feb. 20 upon conclusion of the company’s most recent stockholder’s meeting.

Kathy Mahdoubi

Related Content

Researchers receive grant worth millions to develop portable PET scanner
Why is the US still dependent on foreign medical isotope production?
Downed high-flux reactor could restart sooner than anticipated
Some nuc med departments are already feeling the strain of the isotope shortage
NorthStar opens facility to assist with development and distribution of vital radioisotopes
Lizard saliva could be key to spotting elusive pancreatic tumors

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.